MENU
COCP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Cocrystal Pharma (COCP) Ownership - Who owns Cocrystal Pharma?
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses... Show more
Industry: #Pharmaceuticals Generic
Profile
Industry
Pharmaceuticals Generic
Address
19805 North Creek Parkway
Phone
+1 877 262-7123
Employees
12
Web
https://www.cocrystalpharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
16.58M
P/E Ratio
N/A
Total Cash
13.02M
Projected Growth
N/A
Total Debt
1.88M
Revenue
N/A
Risk (Beta)
1.65
Dividend Yield
N/A
Total Cash/Share
1.28
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
COCP
Capitalization
16.6M
P/E Ratio
N/A
Risk (Beta)
1.65
Dividend Yield
N/A
Total Cash
13M
Total Cash/Share
1.28
Total Debt
1.88M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
12.7M
P/B Ratio
2.27
Cash Flow
N/A
Earnings
-1.84
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
10K
Current Ratio
7.32
Current Revenue Per Employee
39230.77
Dividends Per Share - Security
N/A
EBITDA
-20.31M
Float
N/A
Float - Current
N/A
Gross Income Margin
53.18
Revenue To Assets
-76.57
Shares Held By Institutions
1.97M
Shares Outstanding - Current
10.2M
Total Liabilities
3.53M
Total Volume MTD
N/A
Value
-1
Gain YTD
-29.208
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of novel medicines for use in the treatment of human viral diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Generic
Address
19805 North Creek Parkway
Phone
+1 877 262-7123
Employees
12
Web
https://www.cocrystalpharma.com